{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:37Z","timestamp":1787070997500,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lymph node metastasis (LNM) is a point that often, treatment is not effective in colorectal cancer (CRC). Clinical and pathologic markers of prognosis help clinicians in selecting patients for adjuvant therapy after surgical resection in CRC. MiR-183-5p has been demonstrated to play as an oncogene in CRC, although its biological role still remains unclear. The aim of this study was to evaluate the expression of miR-183-5p in CRC and its potential relevance to clinicopathological characteristics as a prognostic biomarker.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this case\u2013control study, 33 CRC plasma samples at stage I-II-III, as well as plasma samples from 13 healthy controls, were collected. The relative expression levels of miR-183-5p in cancer and the normal samples were measured by quantitative real-time PCR. We analyzed their correlation with clinicopathological parameters and prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Our results indicated that miR-183-5p was significantly overexpressed in CRC samples compared to healthy controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) from a cutoff value of 3.9 with a sensitivity of 89% and a specificity of 91% and an AUC value of 0.74. Further analysis showed that a high plasma expression level of miR-183-5p was significantly associated with LNM and higher tumor\/node\/metastases stage (III) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value\n                      <jats:italic toggle=\"yes\">&lt;<\/jats:italic>\n                      0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In conclusion, the overexpression of miR-183-5p is highly related to advanced clinical stage, LNM and poor prognosis of CRC, indicating that miR-183-5p may serve as a predictive biomarker for the prognosis or the aggressiveness of CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_174_20","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T04:26:59Z","timestamp":1627964819000},"page":"921-926","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Plasma miR-183-5p in colorectal cancer patients as potential predictive lymph node metastasis marker"],"prefix":"10.4103","volume":"18","author":[{"given":"Fatemeh","family":"Sanjabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nekouian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezvan","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20241021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R2-8-20241021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11888-014-0240-7","article-title":"Can circulating microRNAs become the test of choice for colorectal cancer?","volume":"10","author":"Kawamura","year":"2014","journal-title":"Current Colorectal Cancer Rep"},{"key":"R3-8-20241021","doi-asserted-by":"crossref","first-page":"837","DOI":"10.5858\/134.6.837","article-title":"TNM staging system of colorectal carcinoma: A critical appraisal of challenging issues","volume":"134","author":"Puppa","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R4-8-20241021","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1158\/1078-0432.CCR-17-1425","article-title":"Lymph Node Metastases in Colon Cancer Are Polyclonal","volume":"24","author":"Ulintz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R5-8-20241021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bjs.1800810106","article-title":"Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy","volume":"81","author":"Abulafi","year":"1994","journal-title":"Br J Surg"},{"key":"R6-8-20241021","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4240\/wjgs.v8.i3.179","article-title":"Assessment of lymph node involvement in colorectal cancer","volume":"8","author":"Ong","year":"2016","journal-title":"World J Gastrointes Surg"},{"key":"R7-8-20241021","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"R8-8-20241021","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma","volume":"41","author":"Lawrie","year":"2008","journal-title":"Br J Haematol"},{"key":"R9-8-20241021","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.emboj.7601977","article-title":"Messenger RNA regulation: To translate or to degrade","volume":"27","author":"Shyu","year":"2008","journal-title":"EMBO J"},{"key":"R10-8-20241021","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1073\/pnas.0703820104","article-title":"Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5\u2032 UTR as in the 3\u2032 UTR","volume":"104","author":"Lytle","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"R11-8-20241021","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","article-title":"MicroRNAs in cancer management","volume":"13","author":"Kong","year":"2012","journal-title":"Lancet Oncol"},{"key":"R12-8-20241021","doi-asserted-by":"crossref","first-page":"467","DOI":"10.18388\/abp.2012_2079","article-title":"The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment","volume":"59","author":"Tokarz","year":"2012","journal-title":"Acta Biochim Pol"},{"key":"R13-8-20241021","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5483\/BMBRep.2015.48.4.007","article-title":"MicroRNAs: Promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis","volume":"48","author":"Hur","year":"2015","journal-title":"BMB Rep"},{"key":"R14-8-20241021","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ncb1201-1124","article-title":"The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling","volume":"3","author":"Virolle","year":"2001","journal-title":"Nat Cell Biol"},{"key":"R15-8-20241021","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3892\/ol.2017.6265","article-title":"Overexpression of mir-183 and mir-494 promotes proliferation and migration in human breast cancer cell lines","volume":"14","author":"Macedo","year":"2017","journal-title":"Oncol Lett"},{"key":"R16-8-20241021","doi-asserted-by":"crossref","first-page":"e0165261","DOI":"10.1371\/journal.pone.0165261","article-title":"Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer","volume":"11","author":"Zaporozhchenko","year":"2016","journal-title":"PLoS One"},{"key":"R17-8-20241021","doi-asserted-by":"crossref","first-page":"381874","DOI":"10.1155\/2013\/381874","article-title":"Expression and significance of microRNA-183 in hepatocellular carcinoma","volume":"2013","author":"Liang","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"R18-8-20241021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ygyno.2016.02.006","article-title":"MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer","volume":"141","author":"Fan","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R19-8-20241021","first-page":"15.10.1","article-title":"Stem-loop RT-qPCR for miRNAs","volume":"95","author":"Kramer","year":"2011","journal-title":"Curr Protoc Mol Biol"},{"key":"R20-8-20241021","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.surg.2015.04.025","article-title":"Housekeeping genes for studies of plasma microRNA: A need for more precise standardization","volume":"158","author":"Rice","year":"2015","journal-title":"Surgery"},{"key":"R21-8-20241021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/biomedicines6010027","article-title":"The application of gene expression profiling in predictions of occult lymph node metastasis in colorectal cancer patients","volume":"6","author":"Peyravian","year":"2018","journal-title":"Biomedicines"},{"key":"R22-8-20241021","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00268-013-2051-4","article-title":"The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients","volume":"37","author":"Lu","year":"2013","journal-title":"World Journal Surg"},{"key":"R23-8-20241021","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/1055-9965.EPI-11-0035","article-title":"MicroRNA signatures: Novel biomarker for colorectal cancer?","volume":"20","author":"Luo","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R24-8-20241021","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1440-1746.2010.06417.x","article-title":"Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression","volume":"25","author":"Pu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-8-20241021","doi-asserted-by":"crossref","first-page":"e17745","DOI":"10.1371\/journal.pone.0017745","article-title":"Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"R26-8-20241021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/SLA.0b013e3182a6909d","article-title":"Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer","volume":"259","author":"Toiyama","year":"2014","journal-title":"Ann Surg"},{"key":"R27-8-20241021","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"R28-8-20241021","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-8-20241021","first-page":"1000","article-title":"Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development","volume":"10","author":"Falzone","year":"2018","journal-title":"Aging (Albany NY"},{"key":"R30-8-20241021","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/15384047.2014.1002327","article-title":"Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer","volume":"16","author":"Yuan","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"R31-8-20241021","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/1471-2407-14-739","article-title":"MicroRNA expression as risk biomarker of breast cancer metastasis: A pilot retrospective case-cohort study","volume":"14","author":"Marino","year":"2014","journal-title":"BMC Cancer"},{"key":"R32-8-20241021","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.bbamcr.2016.09.004","article-title":"Effects of mutations in Wnt\/\u03b2-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer","volume":"1863","author":"McCubrey","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R33-8-20241021","first-page":"26","article-title":"The prognostic value of microRNA-183 in human cancers: A meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore"},{"key":"R34-8-20241021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MEG.0000000000000002","article-title":"Overexpression of microRNA-183 in human colorectal cancer and its clinical significance","volume":"26","author":"Zhou","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R35-8-20241021","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.repbio.2016.07.002","article-title":"MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4","volume":"16","author":"Cheng","year":"2016","journal-title":"Reprod Biol"},{"key":"R36-8-20241021","doi-asserted-by":"crossref","first-page":"9570","DOI":"10.1158\/0008-5472.CAN-10-2074","article-title":"MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration","volume":"70","author":"Sarver","year":"2010","journal-title":"Cancer Res"},{"key":"R37-8-20241021","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s13277-015-3136-5","article-title":"The functional sites of miRNAs and lncRNAs in gastric carcinogenesis","volume":"36","author":"Wan","year":"2015","journal-title":"Tumour Biol"},{"key":"R38-8-20241021","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3892\/or.2013.2232","article-title":"PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer","volume":"29","author":"Guo","year":"2013","journal-title":"Oncol Rep"},{"key":"R39-8-20241021","first-page":"2519","article-title":"MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4","volume":"7","author":"Gu","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"R40-8-20241021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.cgt.7700896","article-title":"The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin","volume":"13","author":"Baron","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"R41-8-20241021","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-2401-2","article-title":"Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers","volume":"64","author":"Goel","year":"2004","journal-title":"Cancer Res"},{"key":"R42-8-20241021","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3892\/ijmm.2012.1111","article-title":"miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells","volume":"30","author":"Zhao","year":"2012","journal-title":"Int J Mol Med"},{"key":"R43-8-20241021","first-page":"5582","article-title":"MiR-183 inhibits invasion of gastric cancer by targeting Ezrin","volume":"7","author":"Cao","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R44-8-20241021","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.febslet.2008.09.051","article-title":"MicroRNA-183 regulates Ezrin expression in lung cancer cells","volume":"582","author":"Wang","year":"2008","journal-title":"FEBS Lett"},{"key":"R45-8-20241021","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/1471-2407-10-502","article-title":"Dysregulated miR-183 inhibits migration in breast cancer cells","volume":"10","author":"Lowery","year":"2010","journal-title":"BMC Cancer"},{"key":"R46-8-20241021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/1471-2407-11-393","article-title":"Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study","volume":"11","author":"Zhu","year":"2011","journal-title":"BMC Cancer"},{"key":"R47-8-20241021","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1158\/1078-0432.CCR-11-0242","article-title":"MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets","volume":"17","author":"Abraham","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_174_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:07Z","timestamp":1787067607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_174_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_174_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}